Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection Resistant to Drugs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05117788
What this trial is testing

Bioneer Q-RFIA Clinical Evaluation

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 2,350
Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Not applicableStudy completedNCT02727582
What this trial is testing

Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment

Who this might be right for
Multidrug-resistant Tuberculosis
University of Cape Town 142
Not applicableLooking for participantsNCT07396428
What this trial is testing

Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Prescribing in Swiss Primary Care

Who this might be right for
Acute Respiratory InfectionInfluenza-like Illness
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland 200
Testing effectiveness (Phase 2)Ended earlyNCT04575519
What this trial is testing

Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, MDRTuberculosis Infection
Fundació Institut Germans Trias i Pujol 426
Testing effectiveness (Phase 2)Study completedNCT02821832
What this trial is testing

Using Biomarkers to Predict TB Treatment Duration

Who this might be right for
Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 946
Not applicableStudy completedNCT04043793
What this trial is testing

ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients

Who this might be right for
Immunocompromised HostCritical Care
University Hospital, Lille 759
Not applicableEnded earlyNCT03915236
What this trial is testing

Approach for Optimizing Meropenem Therapy in Intubated and Mechanically-Ventilated, Adult Patients With Severe Gram-Negative Lower Respiratory Tract Infection

Who this might be right for
Lower Respiratory Tract Infection
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 7
Large-scale testing (Phase 3)Study completedNCT00002199
What this trial is testing

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Who this might be right for
HIV Infections
Glaxo Wellcome 550
Not applicableLooking for participantsNCT05373758
What this trial is testing

Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa

Who this might be right for
HIV InfectionsAIDSVirologic Failure
Massachusetts General Hospital 648
Testing effectiveness (Phase 2)UnknownNCT03697668
What this trial is testing

Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites

Who this might be right for
Plasmodium Falciparum Malaria (Drug Resistant)
Nurex S.r.l. 50
Large-scale testing (Phase 3)Study completedNCT02589782
What this trial is testing

Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Who this might be right for
Tuberculosis, Multidrug-ResistantExtensively Drug-Resistant TuberculosisTuberculosis, Pulmonary
Medecins Sans Frontieres, Netherlands 552
Large-scale testing (Phase 3)Study completedNCT00021554
What this trial is testing

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

Who this might be right for
HIV Infections
Hoffmann-La Roche 525
Not applicableStudy completedNCT04943588
What this trial is testing

Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs

Who this might be right for
Hepatitis C, Chronic
Queen Mary University of London 25,000
Post-approval studies (Phase 4)UnknownNCT01230580
What this trial is testing

Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)

Who this might be right for
HIV InfectionAcquired Immunodeficiency Syndrome
Medical Research Council 587
Testing effectiveness (Phase 2)Study completedNCT02573350
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

Who this might be right for
Tuberculosis, Multidrug-Resistant
Otsuka Pharmaceutical Development & Commercialization, Inc. 213
Not applicableStudy completedNCT01894347
What this trial is testing

Prospective Observational Pilot-study for the Evaluation of the Nephro- an Neurotoxicity in the Anti-infectious Therapy With Inhalative Colistin Therapy for Patients With Ventilator-associated Pneumonia (VAP)

Who this might be right for
Infection Resistant to Multiple Drugs
Charite University, Berlin, Germany 9
Not applicableStudy completedNCT02063867
What this trial is testing

Active Bathing to Eliminate Infection (ABATE Infection) Trial

Who this might be right for
Healthcare Associated InfectionsMethicillin Resistant Staphylococcus AureusMulti Drug Resistant Organisms
University of California, Irvine 53
Not applicableStudy completedNCT04177654
What this trial is testing

Monitoring Drug Efficacy and Anthelmintic Resistance in Soil-transmitted Helminth Programs

Who this might be right for
Soil-transmitted Helminth Infections
University Ghent 9,457
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Next Page